Talphera, Inc. (TLPH): Total Assets
$29.72M
As of 2025-12-31
$26.81M
As of 2026-06-30
-14.5%
3-year compound annual growth
-14.8%
5-year compound annual growth
-13.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $29.72M | +63.0% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $18.24M | -10.6% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $20.39M | -57.1% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $47.49M | -39.0% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $77.89M | +17.5% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $66.30M | -27.4% | 2022-03-10, Balance as of period end |
| 2019-12-31 | $91.36M | -24.2% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $120.53M | +59.5% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $75.55M | -24.4% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $99.99M | -21.7% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $127.78M | +47.9% | 2017-03-03, Balance as of period end |
| 2014-12-31 | $86.42M | -21.5% | 2016-03-07, Balance as of period end |
| 2013-12-31 | $110.03M | +70.5% | 2015-03-13, Balance as of period end |
| 2012-12-31 | $64.52M | +58.0% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $40.84M | +497.9% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $6.83M | n/a | 2012-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
Compare TLPH, IBO, JUNS, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗